SEC Form 4 · accession 0000899243-18-031207
Solid Biosciences Inc. · SLDB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Juan Andrey Zarur
Director
Period of report
Dec 13, 2018
Accepted (ET)
Dec 17, 2018 · 4:08 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001707502
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Director Stock Option (Right to Buy)F1 | $23.58 | Dec 13, 2018 | A | 10,000 | A | — | Dec 13, 2028 | Common Stock | 10,000 | 10,000 | D |
Explanation of responses
- F1This option was granted on December 13, 2018 and vests in full on the earlier to occur of the one year anniversary of the grant date and immediately prior to the Issuer's first annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events.